← Open Payments lookup

CHARLES FILLINGANE: Open Payments

NPI 1275854465 · MARYVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,236 in 71 payments from 16 companies in 2025. Trend: 2023 $77 · 2024 $1,292 · 2025 $1,236

Food & beverage: $1,221Education: $15
CompanyPaymentsAmount
ABBVIE INC.25$379
Otsuka America Pharmaceutical, Inc.13$201
AstraZeneca Pharmaceuticals LP5$154
PFIZER INC.4$83
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$78
Kowa Pharmaceuticals America, Inc.5$73
Lundbeck LLC3$49
Axsome Therapeutics, Inc.2$43
Ardelyx, Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.2$33

Products named: REXULTI, VRAYLAR, QULIPTA, FARXIGA, UBRELVY, PREVNAR 20, CAPLYTA, ZORYVE.

Industry payments across MO — which companies pay providers there.